An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Cue Health Inc. (NASDAQ: HLTH) will release its fourth quarter and full-year 2022 financial results on March 15, 2023. A conference call will follow at 1:30 p.m. PT / 4:30 p.m. ET to discuss the results and recent highlights. Participants must register in advance to access the live call and will receive dial-in numbers and a personal PIN. Cue Health is known for its innovative healthcare technology, including the first FDA-authorized molecular diagnostic test for at-home use. The company aims to simplify access to health information and diagnostics for individuals and healthcare providers.
Positive
Upcoming release of fourth quarter and full-year 2022 results could attract investor interest.
Cue Health's innovative healthcare solutions position it strongly in the market.
Negative
None.
SAN DIEGO--(BUSINESS WIRE)--
Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its fourth quarter and full-year 2022 financial results on Wednesday, March 15, 2023. In conjunction with the release, Cue will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.
To access the live call via telephone, please register in advance using the link here. Upon registering, each participant will receive an email confirmation with dial-in numbers and a unique personal PIN that can be used to join the call.
The live webinar of the call may be accessed by visiting the Events section of the Company’s website at investors.cuehealth.com. A replay of the webinar will be available on the Company’s website shortly after the conclusion of the call.
About Cue Health
Cue Health (Nasdaq: HLTH) is a healthcare technology company that makes it easier for individuals to access health information and places diagnostic information at the center of care. Cue Health enables people to manage their health through real-time, actionable, and connected health information, offering individuals and their healthcare providers easy access to lab-quality diagnostics anywhere, anytime, in a device that fits in the palm of the hand. Cue Health's first-of-its-kind COVID-19 test was the first FDA-authorized molecular diagnostic test for at-home and over-the-counter use without a prescription and physician supervision. Outside the United States, Cue Health has received the CE mark in the European Union, Interim Order authorization from Health Canada, regulatory approval from India'sCentral Drugs Standard Control Organization, and PSAR authorization from Singapore'sHealth Sciences Authority. Cue was founded in 2010 and is headquartered in San Diego. For more information, please visit www.cuehealth.com.
